Karen Bowden

TL;DR: The studies suggest that therapies inactivating OxPL may be beneficial for reducing generalized inflammation, including the progression of atherosclerosis, aortic stenosis and hepatic steatosis, and reduces inflammation and Atherosclerosis in hypercholesterolaemic mice.

TL;DR: Results indicate that CX3CL1-Fc can inhibit monocyte/endothelial cell adhesion as well as reduce atherosclerosis.

TL;DR: The possibility that patients with obstructive sleep apnea may be susceptible to atherosclerotic disease in the pulmonary vasculature is raised, an observation that has not been previously recognized.

TL;DR: In this Letter, affiliation number 1 was originally missing from the HTML; the affiliations were missing for author Ming-Yow Hung in the HTML, and the Fig. 4 legend erroneously referred to panels a–h, instead of a–g.